Skip to main content

Table 3 Subgroup analysis results of PLR and ovarian cancer survival (OS and PFS)

From: Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review

Subgroup Analysis

Univariate analysis

Heterogeneity P1 value

Multivariate analysis

Heterogeneity P2 value

NO.

ES (95% CI)

NO.

ES (95% CI)

PLR for OS

6

2.53 (2.16-2.96)

0.001

6

1.97 (1.61-2.40)

0.824

Subgroup 1: cut-off

 >  200

4

2.63 (2.23-3.10)

0.002

4

2.06 (1.16-2.56)

0.867

 ≤ 200

2

1.86 (1.15-3.01)

0.74

2

1.47 (0.87-2.48)

0.770

Supgroup 2: sample size

 >  200

2

2.82 (2.31-3.45)

0.000

2

2.02 (1.54-2.65)

0.422

 ≤ 200

4

2.14 (1.67-2.75)

0.193

4

1.91 (1.42-2.55)

0.694

 PLR for PFS

5

2.48 (2.10-2.92)

0.000

5

1.79 (1.46-2.20)

0.810

Subgroup 1: cut-off

 >  200

3

2.75 (2.28-3.31)

0.001

3

1.89 (1.50-2.38)

0.943

 ≤ 200

2

1.70 (1.19-2.42)

0.354

2

1.41 (0.88-2.66)

0.606

Supgroup 2: sample size

 >  200

1

3.85 (2.96-5.01)

/

1

1.95 (1.43-2.66)

/

 ≤ 200

4

1.86 (1.51-2.30)

0.330

4

1.67 (1.27-2.20)

0.788